Vivos (RDGL) Non-Current Debt (2010 - 2019)
Vivos (RDGL) reported Non-Current Debt of $3.1 million for Q1 2019, little changed sequentially from $3.1 million in Q4 2018.
Vivos (RDGL) Non-Current Debt (2010 - 2019) Analysis & Trends
Vivos (RDGL) has 8 years of Non-Current Debt data on file, last reported at $3.1 million in Q1 2019.
- For the quarter ending Q1 2019, Non-Current Debt changed N/A year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2019 stood at $3.1 million (changed N/A YoY), and the FY2018 full-year result was $3.1 million, changed N/A from the prior year.
- Non-Current Debt held at $3.1 million in Q1 2019, from $3.1 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $3.1 million in Q4 2018 to a low of $32279.0 in Q3 2018.
- A 3-year average of $1.7 million and a median of $1.7 million in 2016 frame the typical range for Non-Current Debt.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 3.14 Mn |
| Dec 31, 2018 | 3.14 Mn |
| Sep 30, 2018 | 32,279.00 |
| Jun 30, 2016 | 332,195.00 |
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2013 | 70,000.00 |
| Dec 31, 2012 | 50,000.00 |
| Sep 30, 2012 | 2,760.00 |
| Jun 30, 2012 | 10,155.00 |
| Mar 31, 2012 | 17,354.00 |
| Dec 31, 2011 | 50,500.00 |
| Dec 31, 2010 | 50,000.00 |